Oral absorption of phytosterols and emulsified phytosterols by Sprague-Dawley rats

https://doi.org/10.1016/j.jnutbio.2003.08.013Get rights and content

Abstract

Clinical studies have demonstrated that consumption of phytosterol esters in lipid-based foods decreases serum concentrations of total and LDL cholesterol. These substances represent minimal potential for adverse effects when consumed orally because of their low bioavailability. However, some studies have reported estrogenic and other effects in laboratory animals treated parenterally with phytosterols, demonstrating that these substances may have the potential to cause adverse effects if absorbed. Water-soluble phytosterols have been prepared by formulation with emulsifiers to expand delivery options to include non–lipid-based foods. However, emulsifiers are used as excipients in the formulation of lipophilic pharmaceuticals to increase solubility, thereby increasing their absorption. Therefore, oral consumption of emulsified water-soluble phytosterols could potentially increase their absorption. In the current study, absorption of phytosterols prepared as water-soluble emulsified micelles with two different food-grade emulsifiers was evaluated in Sprague-Dawley rats and compared with absorption of non-micellar free phytosterols and esterified phytosterol mixtures dissolved in a lipophilic vehicle (soybean oil). Rats were dosed via gavage with 42 mg/kg of formulated phytosterol preparations. Blood was collected at 8, 16, 24, and 32 hours, extracted with hexane, derivatized with benzoyl chloride, and analyzed by high-performance liquid chromatography to determine concentrations of β-sitosterol, and campesterol. Plasma concentrations and AUC0–32hours [μg/mL/h] of β-sitosterol and campesterol were lower in plasma obtained from rats treated with emulsified phytosterol preparations than in animals treated with free phytosterols dissolved in soybean oil. Because the pharmacokinetic profile of water-soluble phytosterols is similar to that of phytosterols administered in a lipid vehicle, the safety profile is likely to be the same as that of phytosterols and phytosterol esters in currently used applications.

Introduction

Phytosterols are naturally occurring substances found in plants and that are structurally similar to cholesterol [1]. Although numerous unique phytosterols have been identified, β-sitosterol, campesterol, and stigmasterol account for the largest proportion in most sources [2]. While similar in structure to cholesterol, these phytosterols possess substitutions at position C-24 that are responsible for their poor absorption [3], [4], [5].

Phytosterols inhibit cholesterol absorption from the gastrointestinal system. Many clinical studies have demonstrated significant decreases in serum cholesterol concentrations after consumption of foods into which phytosterols were incorporated [6], [7], [8]. In those studies, phytosterols were administered as fatty acid esters to increase solubility and to facilitate incorporation into lipid-based foods. However, the cholesterol-lowering activity is attributable to the free phytosterols as they are hydrolyzed to free sterols and fatty acids in the gut [9], [10].

Laboratory animals administered phytosterols parenterally have demonstrated adverse effects including evidence of estrogenicity [11], [12], [13]. In contrast, oral exposure to phytosterols does not appear to cause adverse effects. Laboratory rats consuming dietary mixtures of phytosterol or pure β-sitosterol demonstrated no evidence of estrogenic activity even in assays sensitive enough to respond to weakly estrogenic phytochemicals such as coumesterol [14], [15]. From these studies, it appears that the adverse effects of phytosterols are dependent on bioavailability.

Water-soluble phytostanols have been formulated as lecithin emulsified micelles with potential applications in non–lipid-based foods [16]. However, micellar preparations of lipophilic pharmaceuticals are formulated specifically to increase their solubility and hence also their absorption from the gut [17], [18], [19]. Phytosterols formulated with emulsifiers into water-soluble micelles may be more soluble within the gut and have the potential for increased absorption when consumed orally. The present studies were conducted to compare the absorption of emulsified phytosterol micelles with absorption of phytosterols and phytosterol esters in laboratory rats.

Section snippets

Materials

Reference compounds campesterol (C28H48O; MW 400.7), stigmasterol (C24H48O; MW 412.7), β-sitosterol (C29H50O; MW 414.7), and other chemicals including KOH, ethanol, benzoyl chloride, 1,2-dichloroethane, and pyridine were obtained from Sigma Chemical (St. Louis, MO).

Phytosterols and phytosterol esters

The free phytosterols (lot #4763-36-6) used in this work were obtained from soybean oil distillates through a multi-step purification process (Cargill NutriProducts, Eddyville, IA). The product used was a mixture of phytosterols. The

Analytical validation

To validate the ability to detect phytosterols in rat plasma, pure campesterol, stigmasterol, and β-sitosterol were added to plasma from untreated rats. After extraction and derivatization, the samples were analyzed via HPLC as described above (see “Methods and materials” section). Significant concentrations of cholesterol were detected owing to the similarity in structure between cholesterol and the phytosterols. Retention times for cholesterol, campesterol, stigmasterol, and β-sitosterol were

Discussion

Phytosterols are structurally similar to cholesterol [1] except that they possess substitutions at C-24. This substitution appears to be responsible for inhibiting their absorption from the gastrointestinal system [3], [4], [5]. Although Mellanen et al. demonstrated estrogenic activity of phytosterols when evaluated in vitro [21], these compounds exhibit relatively little potential for toxicity because they are poorly absorbed.. Long-term studies on the oral consumption of phytosterols in

Acknowledgements

This study was sponsored by Cargill, Inc., Health and Food Technologies, Wayzata, MN.

References (28)

Cited by (34)

  • Effect of agitation and added cholesterol esterase on bioaccessibility of phytosterols in a standardized in vitro digestion model

    2021, LWT
    Citation Excerpt :

    For over 50 years PS have been shown to reduce serum LDL cholesterol by up to 10% when consumed in adequate quantities (Jones et al., 2018; Ostlund, 2002). Over 250 types of PS have been identified, with beta-sitosterol, campesterol, and stigmasterol being the most abundant (Delaney et al., 2004; Marangoni & Poli, 2010). Some evidence suggests these different PS types can differentially affect cholesterol absorption or inflammation (Sabeva et al., 2011), but the mechanism of action is still unclear.

  • Microencapsulation of Phytosterols by Spray Drying

    2018, Studies in Natural Products Chemistry
    Citation Excerpt :

    Moreover, a typical western diet includes 80 mg/day, whereas 500 mg/day is consumed in vegetarian diets [35,39]. Although the recommended doses are not clearly established, high intakes of phytosterols do not exert side effects, subchronic toxicity, or mutagenic activity [1,7,8,26]. Actually, the Food and Drugs Administration includes the phytosterols, phytostanols, and their esters in the Generally Recognized as Secure (GRAS) list [54].

  • The use of Arabic gum, maltodextrin and surfactants in the microencapsulation of phytosterols by spray drying

    2015, Powder Technology
    Citation Excerpt :

    Emulsification implies the use of high temperatures (above the PS melting point, i.e., ≈ 136 °C) [9,18] or esterified PS (which have lower melting points) [19–21]. However, high temperatures could negatively affect the PS oxidative stability while esterified PS need to be hydrolyzed in order to inhibit cholesterol absorption [22]. On the other hand, the stabilization of aqueous suspensions can be achieved by adding surfactants [23].

View all citing articles on Scopus
View full text